Evaluación de la erupción maculopapular
Summary
Differentials
Common
- Alergia a alimentos o a fármacos
- Picaduras o mordeduras de insectos
- Reacción adversa medicamentosa (p. ej., a un antibiótico, anticonvulsivo o alopurinol)
- Quimioterapia
- Infección por enterovirus y virus ECHO
- Quinta enfermedad (eritema infeccioso)
- Roséola (sexta enfermedad)
- infección por virus de Epstein-Barr (VEB) (mononucleosis infecciosa)
- Infección por citomegalovirus (CMV)
Uncommon
- Reacción adversa no inmediata del medio de contraste yodado
- Necrólisis epidérmica tóxica/síndrome de Stevens-Johnson
- Reacción medicamentosa con eosinofilia y síntomas sistémicos
- Eritema multiforme
- exantema por seroconversión al VIH (también conocido como síndrome retroviral agudo)
- Mpox
- Sepsis
- Infección por virus de la hepatitis B aguda
- Infección por virus de la hepatitis C aguda
- Rubéola (sarampión alemán)
- Rubéola (sarampión)
- Meningococemia
- Escarlatina
- Dermatitis exfoliativa estafilocócica
- Síndrome de shock tóxico (exotoxina de Staphylococcus)
- Fiebre maculosa de las Montañas Rocosas o fiebre maculosa mediterránea
- Enfermedad aguda de injerto contra huésped
- Enfermedad de Kawasaki (síndrome mucocutáneo linfonodular)
- Enfermedad de Still de inicio en la juventud o en adultos
- Sífilis (secundario)
- Enfermedad del Ébola
- Infección por el virus Zika
- Infección por el virus de chikungunya
- Dengue
Contributors
Authors
Adelaide A. Hebert, MD
Professor & Director of Pediatric Dermatology
Department of Dermatology and Pediatrics
UTHealth McGovern Medical School Houston
Houston
TX
Disclosures
AAH has received research grants paid to UTHealth McGovern Medical School Houston from Pfizer, GlaxoSmithKline (GSK), Novan, Dermavant, Arcutis, and Verrica; has received honoraria from Pfizer, Verrica, and Novan; and is on data safety monitoring boards for GSK, Ortho Dermatologics, and Regeneron-Sanofi.
Yamila Goenaga, MD
Dermatology Resident
Department of Dermatology
University of Texas Health Sciences Center in Houston
Houston
TX
Disclosures
YG declares that she has no competing interests.
Alexander J. Jafari, MD, MPH
Clinical Research Fellow
Department of Dermatology
UTHealth McGovern Medical School Houston
Houston
TX
Disclosures
AJJ declares that he has no competing interests.
Acknowledgements
Dr Adelaide A. Hebert, Dr Yamila Goenaga, and Dr. Alexander Jafari would like to gratefully acknowledge Dr Quoc-Bao Nguyen, Dr Mary DarConte, Dr Mark Naftanel, and Dr Hobart W. Walling, previous contributors to this topic.
Disclosures
QN, MD, MN, and HWW declare that they have no competing interests.
Peer reviewers
Brian Swick, MD
Clinical Assistant Professor
University of Iowa College of Medicine
Iowa City
IA
Disclosures
BS declares that he has no competing interests.
Kimberly Schulz, MD
Dermatologist
Town Square Dermatology
Coralville
IA
Disclosures
KS declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Resuscitation Council UK. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. May 2021 [internet publication].Full text
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-73. Abstract
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.Full text Abstract
Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol. 2022 Dec;150(6):1333-93.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Guidelines
- Diagnostic testing for Ebola and Marburg virus diseases: interim guidance, 20 December 2024
- Update on diagnosis and management of kawasaki disease: a scientific statement from the American Heart Association
More GuidelinesPatient information
Hepatitis B: ¿debo vacunarme?
Hepatitis C: ¿qué tratamientos funcionan?
More Patient information
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer